These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 6128652)

  • 1. Selective antagonists at the opiate delta-receptor.
    Shaw JS; Miller L; Turnbull MJ; Gormley JJ; Morley JS
    Life Sci; 1982 Sep 20-27; 31(12-13):1259-62. PubMed ID: 6128652
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential interaction of opiates to multiple "kappa" binding sites in the guinea-pig lumbo-sacral spinal cord.
    Attali B; Gouardères C; Mazarguil H; Audigier Y; Cros J
    Life Sci; 1982 Sep 20-27; 31(12-13):1371-5. PubMed ID: 6128659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different modes of opiate interaction in rat vas deferens.
    Sánchez-Blázquez P; Garzón J; Lee NM
    Life Sci; 1982 Oct 18-25; 31(16-17):1683-6. PubMed ID: 6759825
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative antagonism by naltrexone and naloxone of mu, kappa, and delta agonists.
    Takemori AE; Portoghese PS
    Eur J Pharmacol; 1984 Sep; 104(1-2):101-4. PubMed ID: 6094203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonequilibrium opioid antagonist activity of 6,14-dideoxynaltrexone derivatives.
    Schoenecker JW; Takemori AE; Portoghese PS
    J Med Chem; 1987 Jun; 30(6):1040-4. PubMed ID: 3035177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid receptor affinities of the blood-derived tetrapeptides hemorphin and cytochrophin.
    Liebmann C; Schrader U; Brantl V
    Eur J Pharmacol; 1989 Aug; 166(3):523-6. PubMed ID: 2553436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo evaluation of the opiate delta receptor antagonist ICI 154, 129.
    Gormley JJ; Morley JS; Priestley T; Shaw JS; Turnbull MJ; Wheeler H
    Life Sci; 1982 Sep 20-27; 31(12-13):1263-6. PubMed ID: 6292612
    [No Abstract]   [Full Text] [Related]  

  • 8. Different types of opiate agonists interact distinguishably with mu, delta and kappa opiate binding sites.
    Pfeiffer A; Herz A
    Life Sci; 1982 Sep 20-27; 31(12-13):1355-8. PubMed ID: 6128658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of analgesic potencies of mu, delta and kappa agonists locally applied to various CNS regions relevant to analgesia in rats.
    Satoh M; Kubota A; Iwama T; Wada T; Yasui M; Fujibayashi K; Takagi H
    Life Sci; 1983; 33 Suppl 1():689-92. PubMed ID: 6141508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TENA, a selective kappa opioid receptor antagonist.
    Portoghese PS; Takemori AE
    Life Sci; 1985 Feb; 36(8):801-5. PubMed ID: 2983171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the opioid receptor subtype inhibiting the evoked release of 3H-noradrenaline from guinea-pig atria in vitro.
    Fuder H; Buder M; Riers HD; Rothacher G
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Feb; 332(2):148-55. PubMed ID: 2871496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereospecific inhibition of oxotremorine-induced antinociception by (+)-isomers of opioid antagonists: comparison with opioid receptor agonists.
    Ben-Sreti MM; Sewell RD
    J Pharm Pharmacol; 1982 Aug; 34(8):501-5. PubMed ID: 6126560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid receptors of bovine posterior pituitary neurosecretosomes are exclusively kappa.
    Pesce GO; Lang MA; Cruciani RA; Russell JT; Gainer H; Rodbard D
    NIDA Res Monogr; 1986; 75():77-80. PubMed ID: 2893283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of opioid receptors in the cat carotid body involved in chemosensory depression in vivo.
    Kirby GC; McQueen DS
    Br J Pharmacol; 1986 Aug; 88(4):889-98. PubMed ID: 2874862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved assays for the assessment of kappa- and delta-properties of opioid ligands.
    Ward SJ; Portoghese PS; Takemori AE
    Eur J Pharmacol; 1982 Nov; 85(2):163-70. PubMed ID: 6295778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid receptors in the mouse ileum.
    Smith CF; Waldron C; Brook NA
    Arch Int Pharmacodyn Ther; 1988; 291():122-31. PubMed ID: 2835021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of melphalan-containing N,N-dialkylenkephalin analogues as irreversible antagonists of the delta opioid receptor.
    Lovett JA; Portoghese PS
    J Med Chem; 1987 Sep; 30(9):1668-74. PubMed ID: 3041000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium regulation of agonist binding at opioid receptors. I. Effects of sodium replacement on binding at mu- and delta-type receptors in 7315c and NG108-15 cells and cell membranes.
    Puttfarcken P; Werling LL; Brown SR; Cote TE; Cox BM
    Mol Pharmacol; 1986 Aug; 30(2):81-9. PubMed ID: 3016503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid control of the ruminant stomach motility: functional importance of mu, kappa and delta receptors.
    Ruckebusch Y; Bardon T; Pairet M
    Life Sci; 1984 Oct; 35(17):1731-8. PubMed ID: 6090847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative involvement of receptor subtypes in opioid-induced inhibition of gastrointestinal transit in mice.
    Ward SJ; Takemori AE
    J Pharmacol Exp Ther; 1983 Feb; 224(2):359-63. PubMed ID: 6296358
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.